GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (FRA:9OM1) » Definitions » ROA %

EXMceuticals (FRA:9OM1) ROA % : -826.95% (As of Mar. 2021)


View and export this data going back to 2015. Start your Free Trial

What is EXMceuticals ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. EXMceuticals's annualized Net Income for the quarter that ended in Mar. 2021 was €-6.50 Mil. EXMceuticals's average Total Assets over the quarter that ended in Mar. 2021 was €0.79 Mil. Therefore, EXMceuticals's annualized ROA % for the quarter that ended in Mar. 2021 was -826.95%.

The historical rank and industry rank for EXMceuticals's ROA % or its related term are showing as below:

FRA:9OM1's ROA % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.615
* Ranked among companies with meaningful ROA % only.

EXMceuticals ROA % Historical Data

The historical data trend for EXMceuticals's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals ROA % Chart

EXMceuticals Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -235.05 -438.30 -150.87 -671.84 -493.53

EXMceuticals Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -368.92 -683.89 -640.27 -515.70 -826.95

Competitive Comparison of EXMceuticals's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, EXMceuticals's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EXMceuticals's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EXMceuticals's ROA % distribution charts can be found below:

* The bar in red indicates where EXMceuticals's ROA % falls into.



EXMceuticals ROA % Calculation

EXMceuticals's annualized ROA % for the fiscal year that ended in Jun. 2020 is calculated as:

ROA %=Net Income (A: Jun. 2020 )/( (Total Assets (A: Jun. 2019 )+Total Assets (A: Jun. 2020 ))/ count )
=-6.063/( (1.637+0.82)/ 2 )
=-6.063/1.2285
=-493.53 %

EXMceuticals's annualized ROA % for the quarter that ended in Mar. 2021 is calculated as:

ROA %=Net Income (Q: Mar. 2021 )/( (Total Assets (Q: Dec. 2020 )+Total Assets (Q: Mar. 2021 ))/ count )
=-6.504/( (0.726+0.847)/ 2 )
=-6.504/0.7865
=-826.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2021) net income data. ROA % is displayed in the 30-year financial page.


EXMceuticals  (FRA:9OM1) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2021 )
=Net Income/Total Assets
=-6.504/0.7865
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-6.504 / 0)*(0 / 0.7865)
=Net Margin %*Asset Turnover
=N/A %*0
=-826.95 %

Note: The Net Income data used here is four times the quarterly (Mar. 2021) net income data. The Revenue data used here is four times the quarterly (Mar. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


EXMceuticals ROA % Related Terms

Thank you for viewing the detailed overview of EXMceuticals's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


EXMceuticals (FRA:9OM1) Business Description

Traded in Other Exchanges
N/A
Address
421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9
EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (FRA:9OM1) Headlines

No Headlines